バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測...市場調査レポートについてご紹介

【英文タイトル】Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & growth prospect mapping
4.5. Biosimulation – SWOT Analysis, By Factor (political & legal, economic and technological)
4.6. Industry Analysis – Porter’s
Chapter 5. Market Categorization 1: Product Estimates & Trend Analysis
5.1. Biosimulation market: Product movement analysis
5.2. Software
5.2.1. Software Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3. Services
5.3.1. Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.2. In-house Services
5.3.2.1. In-house Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
5.3.3. Contract Services
5.3.3.1. Contract Services Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: Application Estimates & Trend Analysis
6.1. Biosimulation market: Application movement analysis
6.2. Drug Development
6.2.1. Drug Development Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.3. Drug Discovery
6.3.1. Drug Discovery Market Estimates and Forecasts, 2013 – 2024 (USD Million)
6.4. Others
6.4.1. Others Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: End-use Estimates & Trend Analysis
7.1. Biosimulation market: Application movement analysis
7.2. Pharmaceutical & Biotechnology Companies
7.2.1. Pharmaceutical &Biotechnology Companies Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.3. CROs
7.3.1. CROs Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.4. Regulatory Authorities
7.4.1. Regulatory Authorities Market Estimates and Forecasts, 2013 – 2024 (USD Million)
7.5. Academic Research Institutions
7.5.1. Academic Research Institutions Market Estimates and Forecasts, 2013 – 2024 (USD Million)
Chapter 8. Market Categorization 3: Regional Estimates & Trend Analysis, By Type & Application
8.1. Biosimulation Market Share by Region, 2015 & 2024
8.2. North America
8.2.1. North America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.2.1.1. U.S. Market Estimates and Forecasts
8.2.1.2. Canada Market Estimates and Forecasts
8.2.2. North America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.2.2.1. U.S. Market Estimates and Forecasts
8.2.2.2. Canada Market Estimates and Forecasts
8.2.3. North America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.2.3.1. U.S. Market Estimates and Forecasts
8.2.3.2. Canada Market Estimates and Forecasts
8.3. Europe
8.3.1. Europe Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.3.1.1. UK Market Estimates and Forecasts
8.3.1.2. Germany Market Estimates and Forecasts
8.3.2. Europe Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.3.2.1. UK Market Estimates and Forecasts
8.3.2.2. Germany Market Estimates and Forecasts
8.3.3. Europe Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.3.3.1. UK Market Estimates and Forecasts
8.3.3.2. Germany Market Estimates and Forecasts
8.4. Asia Pacific
8.4.1. Asia Pacific Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.4.1.1. Japan Market Estimates and Forecasts
8.4.1.2. China Market Estimates and Forecasts
8.4.1.3. India Market Estimates and Forecasts
8.4.2. Asia Pacific Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.4.2.1. Japan Market Estimates and Forecasts
8.4.2.2. China Market Estimates and Forecasts
8.4.2.3. India Market Estimates and Forecasts
8.4.3. Asia Pacific Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.4.3.1. Japan Market Estimates and Forecasts
8.4.3.2. China Market Estimates and Forecasts
8.4.3.3. India Market Estimates and Forecasts
8.5. Latin America
8.5.1. Latin America Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.5.1.1. Brazil Market Estimates and Forecasts
8.5.1.2. Mexico Market Estimates and Forecasts
8.5.2. Latin America Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.5.2.1. Brazil Market Estimates and Forecasts
8.5.2.2. Mexico Market Estimates and Forecasts
8.5.3. Latin America Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.5.3.1. Brazil Market Estimates and Forecasts
8.5.3.2. Mexico Market Estimates and Forecasts
8.6. MEA
8.6.1. MEA Market Estimates and Forecasts, By Product, 2013 – 2024 (USD Million)
8.6.1.1. South Africa Market Estimates and Forecasts
8.6.2. MEA Market Estimates and Forecasts, By Application, 2013 – 2024 (USD Million)
8.6.2.1. South Africa Market Estimates and Forecasts
8.6.3. MEA Market Estimates and Forecasts, By End-use, 2013 – 2024 (USD Million)
8.6.3.1. South Africa Market Estimates and Forecasts
Chapter 9. Competitive Landscape
9.1. Strategy framework
9.2. Market participation categorization
9.3. Company Profiles
9.3.1. Certara USA, Inc.
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Simulation Plus, Inc.
9.3.2.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Dassault Systems SA
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Schrodinger, Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Advanced Chemistry Development, Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Chemical Computing Group, Inc.
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Physiomics PLC
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Entelos, Inc.
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Rhenovia Pharma Ltd.
9.3.9.1. Company Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Genedata AG
9.3.10.1. Company Overview
9.3.10.2. Financial Performance
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Leadscope, Inc.
9.3.11.1. Company Overview
9.3.11.2. Financial Performance
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Evidera, Inc.
9.3.12.1. Company Overview
9.3.12.2. Financial Performance
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Insilico Biotechnology AG
9.3.13.1. Company Overview
9.3.13.2. Financial Performance
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. LeadInvent Technologies Pvt. Ltd.
9.3.14.1. Company Overview
9.3.14.2. Financial Performance
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. InhibOx Ltd.
9.3.15.1. Company Overview
9.3.15.2. Financial Performance
9.3.15.3. Product Benchmarking
9.3.15.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:バイオシミュレーションの世界市場分析:製品別(ソフトウェア、サービス、社内サービス、契約サービス)、用途別(薬の開発、薬の発見)、エンドユーザー別(医薬品・バイオテクノロジー企業、CRO、規制当局、学術研究機関)、セグメント予測
■ 英文:Biosimulation Market Analysis By Product (Software, Services, In-house Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, Academic Research Institutions) And Segment Forecasts To 2024
■ 発行日:2016年8月21日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707129
■ 調査対象地域:グローバル
  • Esophageal Cancer:グローバル臨床試験レビューH2, 2013
    Esophageal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Esophageal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Esophageal Cancer. It includes an overview of the trial numbers and their recruitment s …
  • 生物製剤製品物流サービスの世界市場2015-2019
    About bio pharma logistics Logistics deals with the procurement, planning, and implementation of activities in the forward and reverse logistics chain of an organization. The biopharmaceutical industry uses logistics for the complete management of the way resources are acquired, stored, and moved to different end-users. The use of logistics helps the pharmaceutical industry have a continual supply …
  • Woodside Petroleum Limited:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
  • ヘルスケアSCM(サプライチェーン管理)の世界市場:ソフトウェア(在庫、購買)、ハードウェア
    The Global Healthcare Supply Chain Management Market is expected to reach USD 2.22 Billion by 2021 from USD 1.45 Billion in 2016, growing at a CAGR of 8.9% from 2016 to 2021. In this report, the global healthcare supply chain management market has been segmented on the basis of component, delivery mode, and end user. By component, the market is segmented into software and hardware management; the …
  • バイオスティミュラント(生物刺激剤)の世界市場:フミン酸、フルボ酸、海藻抽出物、微生物、微量ミネラル、ビタミン、アミノ酸
    The biostimulants market is projected to grow at a CAGR of 10.4% from 2016 to 2021 and reach a projected value of USD 2.91 Billion by 2021. In terms of area of application, the biostimulants market is projected to grow at a CAGR of 11.7% from 2016 to 2021, to reach USD 24.9 Million hectares by 2021. Factors such as raw material availability and widening applications in row crops such as cereals an …
  • 世界のプラスチック加工機械市場:射出成形機、押出成形機、ブロー成形機など
    About Plastic Processing Machinery Plastic processing machines are used to perform variety of methods to convert plastic materials in the form of pellets, granules, powders, sheets, fluids into formed shapes or parts. After formation of parts, various ancillary operations such as welding, adhesive bonding, machining, and surface decoration are performed to produce the final products. The processin …
  • グローバルにおける石油需要・供給動向
    Increase in Non-OPEC Production to Exceed Growth in Global Oil Demand in 2014, Reducing Call on OPEC Production Summary Report provides a comparison of global oil demand and supply for 2014 versus 2013 detailing the increases in Non-OPEC oil production and its impact on the supply of OPEC crude oil to balance the oil demand / supply position for 2014. Report highlights the areas of significant oil …
  • Strabismus:グローバル臨床試験レビューH1, 2013
    Strabismus Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Strabismus Global Clinical Trials Review, H1, 2013" provides data on the Strabismus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Strabismus. It includes an overview of the trial numbers and their recruitment status as per the site of tri …
  • ネットワーク管理ソリューションの世界市場
    The network management market ecosystem encompasses industry players offering software, solutions and products, equipment vendors, third-party application vendors and system integrators. Prominent players in the network management market space are Cisco, Juniper Networks, IBM, HP, Dell, EMC, Brocade, and BMC Software amongst others. These companies play a critical role in simplifying network manag …
  • 臨床検査試験の世界市場:種類別(CBC、HGB/HCT、BMP、HbA1cテスト、電解質検査、肝パネル)、最終用途別(プライマリークリニック、セントラルラボ)、セグメント予測
    The global clinical laboratory tests market size is expected to reach USD 286.7 billion by 2026 at a 7.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel solutions for maximizing efficiency and minimizing errors is expected to boost the market. Presence of favorable reimbursement policies is anticipated to positively influence the globa …
  • 高性能計算(HPC)の世界市場:サーバ、ストレージ、ネットワークデバイス、ソフトウェア
    The High Performance Computing (HPC) market is estimated to grow from USD 28.08 Billion in 2015 and projected to be of USD 36.62 Billion by 2020, at a high Compound Annual Growth Rate (CAGR) of 5.45% during the forecast period. The scalability of applications, higher processing power, and faster storage solutions is driving the growth of the HPC market. The growth in supercomputing clusters and sc …
  • 世界の不正行為検知及び予防市場2013-2018
    Fraud detection and prevention solutions are the offerings from IT vendors to the enterprises which helps enterprises to detect frauds or prevent occurrences of frauds at early stages. In this report fraud detection and prevention solutions refer to the IT solutions and systems which are used to analyze the data and find anomalies and patterns (to find deterrence from usual course) and the solutio …
  • 心臓用ガイドワイヤー(医療機器)のグローバル市場(2012-2018)
    Global Guidewires sector is projected to reach US$1.6 billion by 2016. The North America accounts for nearly 35% (2015) of the global value while Europe claims approximately 25% (2018). Asia-Pacific is the fastest growing region with a CAGR of 12.8% driving a market value of US$467 million by 2015. On a global scale, projections for Coronary Guidewires market share indicate more than 60% leaving t …
  • miRNAシーケンシングおよびアッセイの世界市場予測(~2024年)
    “The miRNA sequencing and assays market is expected to grow at a CAGR of 11.2% during the forecast period.”The miRNA sequencing and assays market is projected to reach USD 343 million by 2024 from USD 182 million in 2018, at a CAGR of 11.2%. The miRNA sequencing and assays market is driven by various factors such as the advantages of miRNA sequencing over other technologies, increasing research fu …
  • Deep Vein Thrombosis (DVT):グローバル臨床試験レビューH1, 2013
    Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2013" provides data on the Deep Vein Thrombosis (DVT) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Deep Vein Thrombosis (DVT). It includes an overview of the t …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。